Feasibility and costs of a targeted cholera vaccination campaign in Ethiopia

References

• WHO. Cholera vaccines: WHO position paper-Recommendations. Vaccine. 2010;28(30):4687–8. doi:10.1016/j.vaccine.2010.05.008. PMID:20483196.
   PubMed Web of Science ®Google Scholar
• Cholera, 2015. Releve epidemiologique hebdomadaire / Section d'hygiene du Secretariat de la Societe des Nations = Weekly epidemiological record / Health Section of the Secretariat of the League of Nations. 2016;91(38):433–40.
   Google Scholar
• WHO. Cholera. Fact sheet N°107. Updated October 2016. 2015 [cited 2016 3rd June]. Available from: http://www.who.int/mediacentre/factsheets/fs107/en/.
   Google Scholar
• Clemens J, Shin S, Sur D, Nair GB, Holmgren J. New-generation vaccines against cholera. Nat Rev Gastroenterol Hepatol. 2011;8(12):701–10. doi:10.1038/nrgastro.2011.174. PMID:22064524.
   PubMed Web of Science ®Google Scholar
• Martin S, Lopez AL, Bellos A, Deen J, Ali M, Alberti K, Anh DD, Costa A, Grais RF, Legros D, et al. Post-licensure deployment of oral cholera vaccines: a systematic review. Bull World Health Organ. 2014;92(12):881–93. doi:10.2471/BLT.14.139949. PMID:25552772.
   PubMed Web of Science ®Google Scholar
• Kar SK, Sah B, Patnaik B, Kim YH, Kerketta AS, Shin S, Rath SB, Ali M, Mogasale V, Khuntia HK, et al. Mass vaccination with a new, less expensive oral cholera vaccine using public health infrastructure in India: The Odisha model. PLoS Med. 2014;8(2):e2629.
   Google Scholar
• Ciglenecki I, Sakoba K, Luquero FJ, Heile M, Itama C, Mengel M, Grais RF, Verhoustraeten F, Legros D. Feasibility of mass vaccination campaign with oral cholera vaccines in response to an outbreak in Guinea. PLoS medicine. 2013;10(9):e1001512. doi:10.1371/journal.pmed.1001512. PMID:24058301.
   PubMed Web of Science ®Google Scholar
• Porta MI, Lenglet A, de Weerdt S, Crestani R, Sinke R, Frawley MJ, Van Herp M, Zachariah R. Feasibility of a preventive mass vaccination campaign with two doses of oral cholera vaccine during a humanitarian emergency in South Sudan. Trans R Soc Trop Med Hyg. 2014;108(12):810–5. doi:10.1093/trstmh/tru153. PMID:25311798.
   PubMed Web of Science ®Google Scholar
• Hall RH, Sack DA. Introducing cholera vaccination in Asia, Africa and Haiti: A meeting report. Vaccine. 2015;33(4):487–92. doi:10.1016/j.vaccine.2014.11.031. PMID:25437100.
   PubMed Web of Science ®Google Scholar
• Lucas ME, Deen JL, von Seidlein L, Wang XY, Ampuero J, Puri M, Ali M, Ansaruzzaman M, Amos J, Macuamule A, et al. Effectiveness of mass oral cholera vaccination in Beira, Mozambique. N Engl J Med. 2005;352(8):757–67. doi:10.1056/NEJMoa043323. PMID:15728808.
   PubMed Web of Science ®Google Scholar
• Wierzba TF, Kar SK, Mogasale VV, Kerketta AS, You YA, Baral P, Khuntia HK, Ali M, Kim YH, Rath SB, et al. Effectiveness of an oral cholera vaccine campaign to prevent clinically-significant cholera in Odisha State, India. Vaccine. 2015;33(21):2463–9. doi:10.1016/j.vaccine.2015.03.073. PMID:25850019.
   PubMed Web of Science ®Google Scholar
• Ivers LC, Hilaire IJ, Teng JE, Almazor CP, Jerome JG, Ternier R, Boncy J, Buteau J, Murray MB, Harris JB, et al. Effectiveness of reactive oral cholera vaccination in rural Haiti: a case-control study and bias-indicator analysis. Lancet Glob Health. 2015;3(3):e162–8. doi:10.1016/S2214-109X(14)70368-7. PMID:25701994.
   PubMed Web of Science ®Google Scholar
• Luquero FJ, Sack DA. Effectiveness of oral cholera vaccine in Haiti. Lancet Glob Health. 2015;3(3):e120–1. doi:10.1016/S2214-109X(15)70015-X. PMID:25701986.
   PubMed Web of Science ®Google Scholar
• Desai SN, Pezzoli L, Martin S, Costa A, Rodriguez C, Legros D, Perea W. A second affordable oral cholera vaccine: implications for the global vaccine stockpile. Lancet Glob Health. 2016;4(4):e223–4. doi:10.1016/S2214-109X(16)00037-1. PMID:27013303.
   PubMed Web of Science ®Google Scholar
• Desai SN, Clemens JD. An overview of cholera vaccines and their public health implications. Curr Opin Pediatr. 2012;24(1):85–91. doi:10.1097/MOP.0b013e32834eb625. PMID:22157363.
   PubMed Web of Science ®Google Scholar
• Kar SK, Pach A, Sah B, Kerketta AS, Patnaik B, Mogasale V, Kim YH, Rath SB, Shin S, Khuntia HK, et al. Uptake during an oral cholera vaccine pilot demonstration program, Odisha, India. Hum Vaccin Immunother. 2014;10(10):2834–42. doi:10.4161/21645515.2014.971655. PMID:25483631.
   PubMed Web of Science ®Google Scholar
• Ali M, Nelson AR, Lopez AL, Sack DA. Updated global burden of cholera in endemic countries. PLoS Negl Trop Dis. 2015;9(6):e0003832. doi:10.1371/journal.pntd.0003832. PMID:26043000.
   PubMed Web of Science ®Google Scholar
• Mogasale V, Kar SK, Kim J-H, Mogasale VV, Kerketta AS, Patnaik B, Rath SB, Puri MK, You YA, Khuntia HK, et al. An estimation of private household costs to receive free oral cholera vaccine in Odisha, India. PLoS Negl Trop Dis. 2015;9(9):e0004072.
   Google Scholar
• Khan IA, Saha A, Chowdhury F, Khan AI, Uddin MJ, Begum YA, Riaz BK, Islam S, Ali M, Luby SP, et al. Coverage and cost of a large oral cholera vaccination program in a high-risk cholera endemic urban population in Dhaka, Bangladesh. Vaccine. 2013;31(51):6058–64. doi:10.1016/j.vaccine.2013.10.021. PMID:24161413.
   PubMed Web of Science ®Google Scholar
• MSF. Mass Oral Cholera Vaccination Campaign (OCV) in Maban County in the refugee camps and host population in the direct surroundings of the camps. Medecins sans Frontieres Holland. 2012.
   Google Scholar
• Kallenberg J. Gavi's Vaccine Investment Strategy. WHO Product Development for Vaccines Advisory Committee Meeting, 2015 7–9 September, Geneva. Report No.
   Google Scholar
• Gavi. Oral cholera vaccine support. June 8, 2016. Available from: http://www.gavi.org/support/nvs/cholera-vaccine/.
   Google Scholar
• Desai SN, Akalu Z, Teshome S, Teferi M, Yamuah L, Kim DR, Yang JS, Hussein J, Park JY, Jang MS, et al. A Randomized, Placebo-Controlled Trial Evaluating Safety and Immunogenicity of the Killed, Bivalent, Whole-Cell Oral Cholera Vaccine in Ethiopia. Am J Trop Med Hyg. 2015;93(3):527–33. doi:10.4269/ajtmh.14-0683. PMID:26078323.
   PubMed Web of Science ®Google Scholar
• Hsiao A, Desai SN, Mogasale V, Exclerc J-L, Digilio L. Lessons learnt from 12 oral cholera vaccine campaigns in resource-poor settings. WHO Bull. 2017;95:303–12.
   PubMed Web of Science ®Google Scholar
• Morgan W, Levin A, Hutubessy RC, Mogasale V. Costing Oral Cholera Vaccine Delivery Using a Generic Oral Cholera Vaccine Delivery Planning and Costing Tool (CHOLTOOL). International Vaccine Insitute. 2017.
   Google Scholar
• National Bank Of Ethiopia. Inter-bank Daily Foreign Exchange Rate in (USD)- Archive (January 2015 -Novemer 2015) [Internet]. 2015 [cited December 8, 2015]. Available from: http://www.nbe.gov.et/market/dailyexchange.html
   Google Scholar
• Mogasale V, Ramani E, Wee H, Kim J. Oral Cholera Vaccination Delivery Cost in Low- and Middle-Income Countries: An Analysis Based on Systematic Review. PLoS Negl Trop Dis. 2016;10(12):e0005124. doi:10.1371/journal.pntd.0005124. PMID:27930668.
   PubMed Web of Science ®Google Scholar